Cannara Biotech Inc. (LOVE.V)
CAD 0.68
(0.0%)
CAD 0.68
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.08 CAD | 195.82% |
| 2022 | 0.03 CAD | 165.1% |
| 2021 | -0.04 CAD | 78.74% |
| 2020 | -0.19 CAD | 5.0% |
| 2019 | -0.20 CAD | -476.37% |
| 2018 | -0.03 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.04 CAD | -263.68% |
| 2024 Q1 | 0.02 CAD | -54.39% |
| 2024 Q3 | 0.02 CAD | 158.75% |
| 2023 Q4 | 0.05 CAD | 53.59% |
| 2023 Q1 | 0.00 CAD | -97.94% |
| 2023 FY | - CAD | 195.82% |
| 2023 Q2 | -0.01 CAD | -1316.67% |
| 2023 Q3 | 0.03 CAD | 557.53% |
| 2022 FY | - CAD | 165.1% |
| 2022 Q4 | 0.03 CAD | 22.27% |
| 2022 Q3 | 0.02 CAD | 257.62% |
| 2022 Q2 | -0.02 CAD | -42.45% |
| 2022 Q1 | -0.01 CAD | -182.17% |
| 2021 Q2 | -0.01 CAD | 75.32% |
| 2021 Q1 | -0.05 CAD | -9380.0% |
| 2021 Q3 | 0.10 CAD | 954.7% |
| 2021 Q4 | 0.01 CAD | -87.1% |
| 2021 FY | - CAD | 78.74% |
| 2020 FY | - CAD | 5.0% |
| 2020 Q4 | -0.00 CAD | 98.5% |
| 2020 Q3 | -0.03 CAD | 33.07% |
| 2020 Q2 | -0.05 CAD | -29.61% |
| 2020 Q1 | -0.04 CAD | -7600.0% |
| 2019 Q2 | -0.07 CAD | -32950.0% |
| 2019 Q3 | -0.04 CAD | 44.33% |
| 2019 Q4 | -0.00 CAD | 98.64% |
| 2019 FY | - CAD | -476.37% |
| 2019 Q1 | -0.00 CAD | 0.0% |
| 2018 FY | - CAD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | -0.02 CAD | 447.321% |
| CanadaBis Capital Inc. | 0.03 CAD | -140.123% |
| Decibel Cannabis Company Inc. | -0.00 CAD | 1909.302% |
| Delivra Health Brands Inc. | 0.00 CAD | -2409.677% |
| Entourage Health Corp. | -0.15 CAD | 151.867% |
| Lifeist Wellness Inc. | -0.58 CAD | 113.414% |
| Medicure Inc. | -0.09 CAD | 188.109% |
| PharmaCielo Ltd. | -0.10 CAD | 177.8% |
| Rubicon Organics Inc. | -0.03 CAD | 340.867% |
| BioSyent Inc. | 0.54 CAD | 85.593% |
| Voyageur Pharmaceuticals Ltd. | -0.01 CAD | 827.103% |